Plasma FGF-21 levels in type 2 diabetic patients with ketosis

Diabetes Research and Clinical Practice
Ling LiWenwen Chen

Abstract

FGF-21 has been recently characterized as a potent metabolic regulator, but its pathophysiologic role in human remains unknown. In this study we investigate whether plasma FGF-21 level is different in patients with new-onset type 2 diabetes mellitus (T2DM) and diabetic ketosis (T2DK). Sixty-eight patients with T2DM, 41 subjects with T2DK, and 52 sex- and age-matched normal controls participated in the study. Plasma FGF-21 levels were measured with a radioimmunoassay. The relationship between plasma FGF-21 levels and anthropometric and metabolic parameters was also analyzed. Plasma FGF-21 levels were higher in patients with T2DK and T2DM than in controls (4.05+/-0.18microg/L and 2.82+/-0.14microg/L vs. 2.28+/-0.16microg/L, P<0.01 and P<0.05, respectively). Fasting plasma FGF-21 was found to correlate positively and significantly with SBP, DBP, FBG, 2hPBG, HbA(1)c, HDL-C and FFA, but negatively with fasting plasma insulin, 2hIns and HOMA(IS). Multiple regression analysis showed that DBP, WHR, 2hIns, 2hPBG and FFA were independent to the factors influencing plasma FGF-21 levels. Increasing concentrations of FGF-21 were independently and significantly associated with T2DM and T2DK. The present work suggests that FGF-21 may play a r...Continue Reading

References

Feb 5, 1999·Biochimica Et Biophysica Acta·T NishimuraN Itoh
Jun 20, 2000·Biochimica Et Biophysica Acta·T NishimuraN Itoh
Nov 4, 2000·Biochemical and Biophysical Research Communications·H OhuchiN Itoh
Apr 18, 2002·Genes & Development·Hiroshi SakaueNobuyuki Itoh
Mar 18, 2005·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·B KnebelD Müller-Wieland
May 20, 2005·The Journal of Clinical Investigation·Alexei KharitonenkovArmen B Shanafelt

❮ Previous
Next ❯

Citations

Feb 25, 2011·The American Journal of Clinical Nutrition·Eleni M Domouzoglou, Eleftheria Maratos-Flier
Nov 13, 2009·The American Journal of Clinical Nutrition·Steven A Kliewer, David J Mangelsdorf
Jun 6, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·E B NygaardB Andersen
Mar 12, 2009·Cellular and Molecular Life Sciences : CMLS·Mikael Rydén
May 1, 2009·Diabetes/metabolism Research and Reviews
Feb 11, 2011·Diabetes/metabolism Research and Reviews·Fredirick L MashiliAnna Krook
Oct 7, 2015·Frontiers in Endocrinology·Bin NiFrancesco S Celi
Apr 7, 2010·Metabolism: Clinical and Experimental·Knut MaiJoachim Spranger
Oct 7, 2011·Endocrine Research·Xingbo ChengHuaying Fan
Jun 6, 2014·BioMed Research International·Xiao-shan WanXiao-kun Li
May 11, 2010·Gastroenterology·Jody DushayEleftheria Maratos-Flier
Sep 25, 2017·Endocrine Reviews·Harald StaigerHans-Ulrich Häring
Nov 8, 2018·The British Journal of Nutrition·David J ClaytonLewis J James
Oct 15, 2010·American Journal of Physiology. Endocrinology and Metabolism·Maximilian BielohubyMartin Bidlingmaier
Jun 26, 2020·Journal of Cellular Physiology·Chang GuoGuoyue Yuan
Apr 29, 2010·American Journal of Physiology. Endocrinology and Metabolism·Knut MaiJoachim Spranger
May 22, 2010·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Suheyla GorarYalcin Aral
Aug 2, 2015·American Journal of Physiology. Heart and Circulatory Physiology·Eleni M DomouzoglouEleftheria Maratos-Flier
Aug 2, 2017·Scientific Reports·Jyoti RaniSrinivasan Ramachandran
Nov 24, 2016·Journal of Internal Medicine·A Kharitonenkov, R DiMarchi
Oct 20, 2020·Endocrine Research·Esben Stistrup LauritzenMette Bjerre
May 22, 2021·PloS One·Arguiñe Ivonne Urraza-RobledoFrancisco Carlos López-Márquez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.